Live feed08:45:00·6mPRReleasevia QuantisnowArtelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026ByQuantisnow·Wall Street's wire, on your screen.ARTL· Artelo Biosciences Inc.Health Care
